Futu News report on July 14, this Thursday $MICROPORT NEURO (02172.HK)$Announcement was made. The company is issuing 13.7 million shares at a price of HKD 24.64 per share, with each lot consisting of 1,000 shares. It is expected to be listed on July 15.
During the public offering phase, MicroPort NeuroScience received 45.27 times subscription. The final number of shares allocated to the public offering amounted to 4.11 million shares, accounting for approximately 30% of the total offering (before any over-allotment option was exercised). A total of 9,320 valid applications were received, with a winning rate of 4.88% for one lot, and subscribing for 25 lots guarantees one winning lot.
In addition, the international offering was oversubscribed, with the final number of shares amounting to approximately 9.59 million shares, equivalent to about 70% of the total offering (before any over-allotment option was exercised). Futu News compiled relevant data as shown in the table below.
The company plans to use the net proceeds from the global offering, approximately HKD 278 million, for the following purposes: about 30.0% will be used for R&D of products for treating hemorrhagic stroke, cerebral atherosclerosis stenosis, and acute ischemic stroke; about 20.0% will be used for commercializing products related to hemorrhagic stroke, cerebral atherosclerosis stenosis, and acute ischemic stroke; about 15.0% will be used for expanding manufacturing facilities to increase production scale; about 20.0% will be used for expanding global presence; about 10.0% will be used for optimizing the product portfolio through strategic acquisitions, investments, collaborations, or a combination of these strategies; about 5.0...